OCV
- Company typePrivate
- Founded2016
- HeadquartersLos Angeles, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
OCV firmographics
Firmographics- Name
- OCV
- Legal name
- OCV Management LLC
- Website
- https://ocvpartners.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
OCV industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Corporate Venture Capital (CVC) (FSANAAAF)
- akta.pro secondary industries
- Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF), Strategic / Balance-Sheet CVC (On-balance-sheet investing) (FSANAHAA)
Keywords
Where OCV is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
OCV business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Fund Management: OCV generates returns through management fees and carried interest from their venture funds. They invest in portfolio companies and realize returns through exits via IPOs and acquisitions.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
OCV product offering
Product offeringCore offering
OCV Partners is a Los Angeles-based venture capital firm that provides equity capital and operational expertise to early and growth-stage technology and healthcare companies. The firm deploys flexible capital across all stages of a company's growth cycle and combines investment with hands-on company-building support from former founders. Its investment focus spans Technology (SaaS, FinTech, PropTech) and Healthcare (Healthcare SaaS, Digital Health, MedTech, BioTech) sectors.
Product overview
OCV Partners operates as a single unified investment platform rather than a modular product suite. The firm provides venture capital investment services to portfolio companies, offering flexible capital deployment across all growth stages, from early-stage to IPO and beyond. Their core offering combines equity investment with operational expertise, leveraging the team's experience from building companies that have scaled across industries and countries. The firm focuses on two primary sectors: Technology (SaaS, FinTech, and PropTech) and Healthcare (Healthcare SaaS, Digital Health, MedTech, and BioTech).
Differentiator
Problem solved
Functional benefit
Products and services
- OCV Partners Investment Services Venture capital investment services providing flexible equity capital and operational expertise to early and growth-stage technology and healthcare companies. OCV invests across all stages of a company's growth cycle and supports portfolio companies in SaaS, FinTech, PropTech, Healthcare SaaS, Digital Health, MedTech, and BioTech sectors with board representation, strategic guidance, and operational support.
Quantifiable outcome
- 165+ software companies acquired through J2 Global experience
- +1 more outcomes
Companies that use OCV
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles3 records
OCV technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
OCV partnerships and signals
Strategic signalScale indicators9 records
Recent moves9 records
Expansion highlights5 records
OCV competitors and assessment
Company assessmentDirect peers
- Khosla Ventures: Venture capital firm with a strong focus on technology and healthcare investments. Direct co-investor with OCV in Rad AI, where Khosla led the Series B. Highly comparable in stage focus (Series A-C) and sector overlap (SaaS, AI, biotech).
- Polaris Partners: Healthcare and technology-focused venture capital firm. Co-led ByHeart's Series A alongside OCV. Directly comparable in healthcare/biotech investment thesis and stage focus.
- Artis Ventures: Early-to-growth stage venture firm investing at the intersection of technology and health/life sciences. Led Rad AI Series A and participated in subsequent rounds alongside OCV — directly comparable in stage and sector thesis.
- MizMaa Ventures: Israel-focused venture capital firm investing in deep tech and enterprise software. Co-invested with OCV in Orca AI across multiple rounds; directly comparable as an early-stage tech investor with strong Israeli sourcing.
- D1 Capital Partners: Technology-focused investment firm backing growth-stage companies. Co-led ByHeart's Series A with OCV. Comparable in stage focus (growth equity) and consumer/health tech overlap.
- ArrowMark Partners: Investment manager focused on public and private growth companies. Led Precision BioSciences Series B with OCV participation. Comparable in growth-stage biotech and tech investing.
Broad incumbents
- Andreessen Horowitz (a16z): Major technology-focused venture capital firm with broad coverage across SaaS, fintech, healthcare, and bio. Operates at significantly larger fund sizes but with overlapping sector thesis (SaaS, healthcare, AI) and similar stage flexibility.
- General Catalyst: Multi-stage venture capital firm investing across technology and healthcare, including digital health and biotech. Larger and more diversified than OCV but with overlapping thesis and operating value-add orientation.
- Bessemer Venture Partners: Long-established venture capital firm with deep SaaS and subscription software expertise — directly mirroring OCV's stated SaaS/subscription focus and operating playbook heritage from J2 Global.
Emerging players
- Section 32: Venture firm founded by Bill Maris investing at the intersection of technology and healthcare/life sciences. Comparable in mid-sized fund profile, tech-healthcare crossover thesis, and stage focus similar to OCV.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
OCV social profiles
Digital presenceOCV financial estimates
Financial estimateRevenue estimate
Valuation estimate
OCV leadership team
Management profileNumber of profiles
Profiles4 records
OCV funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OCV M&A and investment
M&A and investmentM&A
Investments21 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OCV
What does OCV do?
OCV Partners is a Los Angeles-based venture capital firm that provides equity capital and operational expertise to early and growth-stage technology and healthcare companies. The firm deploys flexible capital across all stages of a company's growth cycle and combines investment with hands-on company-building support from former founders. Its investment focus spans Technology (SaaS, FinTech, PropTech) and Healthcare (Healthcare SaaS, Digital Health, MedTech, BioTech) sectors.
Is OCV a public or private company?
OCV is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was OCV founded?
OCV was founded in 2016. It employs 11 to 50 people.
Where is OCV based?
OCV is headquartered in Los Angeles, United States, in the North America region.
How does OCV make money?
One revenue line is on record: fund Management.
Who are OCV's main competitors?
Direct peers on record are Khosla Ventures, Polaris Partners, Artis Ventures, MizMaa Ventures, D1 Capital Partners and ArrowMark Partners. Broad incumbents are Andreessen Horowitz (a16z), General Catalyst and Bessemer Venture Partners. Section 32 is listed as an emerging player.
Does OCV have an API?
No public API is recorded for OCV.
What industry is OCV in?
OCV's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAF, Corporate Venture Capital (CVC), with a secondary code of FSANAHAF, Corporate Strategic Partnership & Ecosystem Investment Arms. Its NAICS code is 523940 and its SIC code is 6282.